In a short-term perspective, the company has interesting fundamentals.
The current area is a good opportunity for investors interested in buying the stock in a mid or long-term perspective. Indeed, the share is moving closer to its lower bound at BRL 23.35 BRL in weekly data.
The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
For several months, analysts have been revising their EPS estimates roughly upwards.
Analysts covering this company mostly recommend stock overweighting or purchase.
The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
The tendency within the weekly time frame is positive above the technical support level at 23.35 BRL
According to forecast, a sluggish sales growth is expected for the next fiscal years.
The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
The group usually releases earnings worse than estimated.
The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.